Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D S Burgess

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Chest|March 20, 1999
Pharmacodynamic principles of antimicrobial therapy in the prevention of resistanceD S Burgess
Diagnostic Microbiology and Infectious Disease|October 12, 2000
Activity of piperacillin/tazobactam in combination with amikacin, ciprofloxacin, and trovafloxacin against Pseudomonas aeruginosa by time-killD S Burgess, R W Hastings
JAMA|May 20, 2000
A critical pathway for treatment of community-acquired pneumoniaD S Burgess, J S Lewis
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|April 12, 2005
Continuous infusion beta-lactams for intensive care unit pulmonary infectionsC R Frei, D S Burgess
Diagnostic Microbiology and Infectious Disease|October 18, 2000
A comparison of dynamic characteristics of fluconazole, itraconazole, and amphotericin B against Cryptococcus neoformans using time-kill methodologyD S Burgess, R W Hastings
Clinical Therapeutics|August 17, 2000
Effect of macrolides as part of initial empiric therapy on medical outcomes for hospitalized patients with community-acquired pneumoniaD S Burgess, J S Lewis
Pharmacotherapy|November 23, 2001
Extended-spectrum beta-lactamases: epidemiology, detection, and treatmentS Nathisuwan, D S Burgess, J S Lewis
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|April 21, 2018
Polymyxin B Etest<sup>®</sup> compared with gold-standard broth microdilution in carbapenem-resistant Enterobacteriaceae exhibiting a wide range of polymyxin B MICsB Kulengowski, J A Ribes, D S Burgess
Clinical Therapeutics|July 13, 2000
Pharmacokinetics and pharmacodynamics of aztreonam administered by continuous intravenous infusionD S Burgess, K K Summers, T C Hardin
Clinical Therapeutics|February 25, 2000
Pharmacokinetics and pharmacodynamics of cefepime administered by intermittent and continuous infusionD S Burgess, R W Hastings, T C Hardin
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Chest|March 20, 1999
Pharmacodynamic principles of antimicrobial therapy in the prevention of resistanceD S Burgess
Diagnostic Microbiology and Infectious Disease|October 12, 2000
Activity of piperacillin/tazobactam in combination with amikacin, ciprofloxacin, and trovafloxacin against Pseudomonas aeruginosa by time-killD S Burgess, R W Hastings
JAMA|May 20, 2000
A critical pathway for treatment of community-acquired pneumoniaD S Burgess, J S Lewis
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|April 12, 2005
Continuous infusion beta-lactams for intensive care unit pulmonary infectionsC R Frei, D S Burgess
Diagnostic Microbiology and Infectious Disease|October 18, 2000
A comparison of dynamic characteristics of fluconazole, itraconazole, and amphotericin B against Cryptococcus neoformans using time-kill methodologyD S Burgess, R W Hastings
Clinical Therapeutics|August 17, 2000
Effect of macrolides as part of initial empiric therapy on medical outcomes for hospitalized patients with community-acquired pneumoniaD S Burgess, J S Lewis
Pharmacotherapy|November 23, 2001
Extended-spectrum beta-lactamases: epidemiology, detection, and treatmentS Nathisuwan, D S Burgess, J S Lewis
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|April 21, 2018
Polymyxin B Etest<sup>®</sup> compared with gold-standard broth microdilution in carbapenem-resistant Enterobacteriaceae exhibiting a wide range of polymyxin B MICsB Kulengowski, J A Ribes, D S Burgess
Clinical Therapeutics|July 13, 2000
Pharmacokinetics and pharmacodynamics of aztreonam administered by continuous intravenous infusionD S Burgess, K K Summers, T C Hardin
Clinical Therapeutics|February 25, 2000
Pharmacokinetics and pharmacodynamics of cefepime administered by intermittent and continuous infusionD S Burgess, R W Hastings, T C Hardin
Pageof 2